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Abstract
Background: This study describes the feasibility of Contrast Enhanced Ultrasonography (CEUS) in the diagnostic
work-up of non-cardiac thoracic disorders of small animals. The second aim is to assess the usefulness of CEUS as a
direct guide for sample procedures.
Results: Forty animals, 28 dogs and 12 cats, were included in the study. Thoracic disorders included 23 pulmonary
lesions [primary carcinoma (14), lymphoma (1), sarcoma (1), histiocytic sarcoma (1), abscess (1) and pneumonia (5)]
and 17 mediastinal lesions [lymphoma (8), thymoma (3), mesothelioma (1), melanoma (1), carcinomatous
lymphadenopathy (1), mixsosarcoma (1), lipoma (1), and abscess (1)]. The majority of neoplastic pulmonary lesions
showed an inhomogeneous distribution of contrast medium, whereas inflammatory lesions had a homogenous
distribution with typical pulmonary vessels ramification. The majority of mediastinal malignant lesions showed an
inhomogeneous distribution pattern. The lung and mediastinal abscesses had peripheral enhancement of the wall
with an avascular center. All cytological and biopsy samples obtained after CEUS were diagnostic. Quantitative
analysis, performed in 19/23 pulmonary lesions, showed a statistically significant difference (P < 0.0001) between
the arrival time of the malignant (7.27 s - range 4.46–13.52 s) and benign (4.52 s - range 2.87–6.06 s) pulmonary
lesions.
Conclusions: CEUS may be a useful tool for the evaluation of non-cardiac thoracic lesions. The contrast medium
allows for the precise definition of lesion edges, the presence of necrotic areas, and the distribution of pulmonary
vessels.
Based on our preliminary results, the use of ultrasonographic contrast medium can be recommended for improving
the diagnostic usefulness of cytology and biopsy sampling, because CEUS may help to define necrotic areas from
viable tissue.
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Background
Thoracic ultrasounds are an important supplemental
imaging modality in the diagnosis of non-cardiac thor-
acic disorders [1–3]. In veterinary medicine, several
studies have addressed the usefulness of conventional
ultrasounds for evaluating interstitial lung disease,
during chronic conditions and emergency settings [4–6].
In the latter scenario, conventional ultrasounds have
become of essential aid to increase diagnostic accuracy
in traumatized patients or in animals with lung edema
[7–9]. Since sound waves do not propagate through the
air, this technique is limited to the evaluation of struc-
tures within or adjacent to the thoracic wall or to the
presence of pleural effusion that creates an acoustic win-
dow allowing visualization of the intrathoracic structures
[1–3]. Thoracic ultrasonography is also employed to
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guide interventional procedures (i.e., thoracentesis or bi-
opsy of mediastinal and peripheral lung masses) to in-
crease efficiency and safety [3].
In human medicine, the role of contrast-enhanced
ultrasonography (CEUS) in the diagnosis of pathological
conditions of the thorax and the appearances of different
non-cardiac thoracic lesions have been reported [10–15].
Based on the dual arterial blood supply of the lung (i.e.,
pulmonary and bronchial arteries), the behavior of con-
trast medium in the lung parenchyma is similar to the
liver (i.e., dual vascular supply characterized by arterial
and portal feeding). This means that intravenously
injected contrast medium reaches the lungs in the early
phase (2–6 s after inoculation) via the pulmonary arter-
ies and immediately after (7–20 s after inoculation) via
the bronchial arteries and is eliminated in the late phase
through the pulmonary and bronchial veins [11, 15].
The two most important parameters used in human
medicine to discriminate benign from malignant lesions is
the time until contrast enhancement and the distribution
of the contrast medium. Specifically, benign lesions such
as pneumonia commonly have a short time to enhance-
ment and show intense and homogenous tissue enhance-
ment with a regular, tree-like distribution of pulmonary
arterial vessels. On the contrary, neoplastic lesions often
present neoangiogenesis originating mainly from the
bronchial arteries, creating an inhomogeneous tissue
enhancement because of chaotic vascularization [11, 15].
In human medicine, CEUS is also used as a guide for
transthoracic biopsy to allow for the differentiation of
necrotic tissue from perfused tissue to identify the most
appropriate sampling sites [16–18].
To our knowledge, information regarding the use of
CEUS for the evaluation of non-cardiac thoracic disor-
ders in veterinary literature is limited to a series of three
cases of lung lobe torsion [19] and an abstract collecting
of 15 cases with peripheral pulmonary and mediastinal
mass lesions [20]. The first aim of this study was to
prospectively assess the feasibility of CEUS in the
characterization of non-cardiac thoracic disorders of
small animals and to describe the CEUS pattern of
pulmonary and mediastinal lesions. The second aim was
to assess the usefulness of CEUS as a direct guide for
sampling procedures.
Methods
Study population
Animals were prospectively recruited at the Veterinary
Teaching Hospital of the University of Bologna from
January 2010 to March 2015. Patients were enrolled into
the study if they had a diagnosis of non-cardiac intra-
thoracic lesions observed with conventional ultrasound,
including peripheral lung lesions abutting the pleural
surface and mediastinal lesions. Moreover, each patient
must have had CEUS of the thoracic lesion performed
and of sufficient quality to be subsequently evaluated. A
final diagnosis of the lesion, through cytological or
histological examinations, was a mandatory inclusion
criterion.
Exclusion criteria were:
1) Technically inaccessible lesions (lesions that could
not be visualized or poorly visualized with conventional
ultrasound; or lesions not reachable for sample
collection);
2) Severe dyspnea that could not be stabilized within
24 h from ultrasonographic exam;
3) CEUS not performed or of poor quality;
4) Inconclusive or missing final pathological diagnosis;
5) Clinical and radiographic features suggestive of
cardiac disorders.
Informed owner consent was obtained before each
CEUS examination and all procedures were performed
in accordance with Italian laws on animal care.
Ultrasound procedures and analysis
All procedures were conducted by the same experienced
ultrasonographer (AD), using a real-time ultrasound ma-
chine1 equipped with a Micronvex probe (5–8 MHz), a
broadband curved array transducer (2–5 MHz), and a
linear array transducer (3–9 MHz). Conventional ultra-
sound and CEUS examination were performed within
24 h from admission and patient stabilization when
needed. All patients received a survey of thoracic radio-
graphs during their diagnostic work up. The time
between radiographic and ultrasonographic study was
less than 24 h. The animals were awake and restrained
manually during the ultrasonographic procedures. Base-
line grey-scale and color imaging was initially performed
to localize the thoracic lesion and determine the optimal
intercostal window for subsequent assessment. Each
lesion was characterized by location, shape, size, echo-
genicity, and echotexture. The ultrasound setting was
then switched to the Pulse Inversion Harmonic and
Power Modulation combined (PMPI) with a low
mechanical index set (0.07) for the contrast enhanced
ultrasound. The gain setting was regulated to obtain
anechoic thoracic lesions at baseline and a focal zone
was placed just below the lesions to minimize microbub-
ble destruction. The frame rate of CEUS loops varied
between 10 and 30 Hz. With the transducer held in a
fixed stable position, a bolus injection of SonoVue2
(0.5 ml for cats and 0.05 ml/kg for dogs) was manually
injected through an indwelling cephalic venous catheter
(20 or 22G), followed immediately by a rapid bolus of
4 mL saline. The images were recorded as cine-segments
in DICOM format of 120 s starting from the time of
contrast medium injection and then transferred to a
personal computer.
Linta et al. BMC Veterinary Research  (2017) 13:141 Page 2 of 10
Show Case software3 was used to review the images
and to export selected frames for qualitative analysis.
The distribution of the contrast medium enhancement
within the lesions was evaluated subjectively as homoge-
neous or inhomogeneous during contrast uptake (wash-
in phase), at peak intensity and during the progressive
wash-out of contrast medium. Other specific findings
were noted such as linear hyperechoic structures due to
pulmonary vessel enhancement, anechoic areas inside
the lesion, or peripheral enhancement of the lesion.
Commercial software4 was used for quantitative comput-
erized analysis of the contrast medium blood pool phase
of the pulmonary lesions as previously described by our
group for other organs [21, 22]. A region of interest
(ROI) was manually drawn in the lesion as large as
reasonably achievable, avoiding adjacent major vessels,
and the presence of residual pulmonary air. The ROI
was maintained in the same position by the motion
compensation tool from QLAB software. This tool pre-
vents the displacement of the ROI during respiratory
motion. Furthermore, the ROI was adjusted manually on
those frames severely affected by respiratory motion.
Artefactual data from adjacent pulmonary tissue that
moved into the ROI during respiratory motion were
manually removed from the final dataset to reduce noise.
The raw data obtained from each patient were plotted in
quantitative time-intensity curves after the data were
fitted to a mathematical model curve. The following
perfusion variables were recorded: arrival time (AT,
expressed in sec), defined as the time when the contrast
signal is increasing to greater than about 10% of the
peak intensity; time to peak from injection (TTPinj,
expressed in sec); time to peak from initial rise (TTPinr,
expressed in sec) calculated as TTPinj – AT; peak inten-
sity (PI, expressed in arbitrary units [a.u.]) was defined
as the highest intensity value minus baseline intensity
before the initial rise; and wash-in rate (Wi, expressed in
a.u./sec) was calculated with the data 10% above baseline
intensity (BI) up to 85% of the peak value using a linear
regression.
Sample collection
Immediately after the completion of CEUS, dogs were
sedated and ultrasound-guided fine needle aspiration
(FNA) and/or tissue core biopsy (TB) were performed.
The information obtained from the contrast medium
distribution was used to select sampling sites (areas
showing contrast enhancement within the lesion; Fig. 1).
Fine needle aspiration of the lesions was performed
using a 22-gauge spinal needle,5 whereas TB was carried
out with 14- (for dogs) and 16- (for cats) gauge Tru-
Cut-type semiautomatic needles with a 20-mm specimen
notch at the tip.6 In specific cases, cytological and/or
histological sampling though bronchoscopy was allowed,
providing that this was diagnostic. The endoscopic
procedure was performed on the same day as CEUS.
Statistical analysis
The data obtained from the quantitative perfusion
analysis of the pulmonary lesions were regressed for
significance of linearity using a D’Agostino-Pearson test
and expressed as median and range. A Mann-Whitney
Fig. 1 Transverse scan of a domestic shorthair cat with mediastinal thymoma in the contrast enhancement image (a) and the grey scale image
(b) respectively. During the peak enhancement the contrast medium revealed a greater irregular avascular area (dotted line) (a) in comparison to
grey scale image (b)
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test was used to compare the results of perfusion param-
eters between malignant and benign pulmonary lesions.
A P-value less than 0.05 was considered statistically
significant. Statistical analyses were performed using a
commercial software package.7
Results
Forty animals (28 dogs and 12 cats) with intra-thoracic
diseases were included in the study. In the group of
dogs, mixed breeds were overrepresented (13/28 dogs).
There were three Labrador retrievers, two Rottweilers,
two Basset hounds, and one each of the following
breeds: Golden retriever, Great Dane, German shepherd,
Dogue de Bordeaux, Weimaraner, Cocker spaniel, Bern-
ese mountain dog, and English setter. There were 14 in-
tact and two neutered males, and four intact and eight
neutered females. The mean age was 8.6 ± 3.5 years.
Among the group of cats, there were 11/12 domestic
shorthair cats and one Chartreux, made up of two intact
and four neutered males, and two intact and four
neutered females. The median age was 8.8 ± 3.8 years.
A total of 40 lesions were examined, including 23
pulmonary lesions and 17 mediastinal lesions. The diam-
eter of the pulmonary lesions ranged from 1 to 18.3 cm.
Four lesions were located in the left apical lobe, two in
the right apical lobe, five in the right medial lobe, seven
in the left diaphragmatic lobe, and 10 in the right
diaphragmatic lobe. The diameter of the mediastinal le-
sions ranged from 1.6–12.4 cm. Fifteen lesions were
located in the cranial mediastinum and two in the
caudal mediastinum.
Of the 40 cases, 32 had malignant lesions and eight
had benign lesions. For the malignant lesions, the
diagnosis was obtained by cytological and histological
confirmation following CEUS on 25 and seven cases,
respectively. In cases of benign lesions, the diagnosis
was based on cytology following CEUS in three patients
and on histology following bronchoscopic biopsy in the
other five cases. All cytological and biopsy samples
obtained after CEUS were diagnostic. Table 1 reports the
final diagnoses.
Tables 2 and 3 summarize the results of baseline grey-
scale ultrasonography of pulmonary and mediastinal
lesions, respectively. The malignant pulmonary lesions
had a round-oval shape and hypoechoic appearance. The
echotexture was inhomogeneous in all cases. Five benign
pulmonary lesions showed a triangular shape with a
liver-like appearance associated with images of air and
fluid bronchograms. Most of the malignant mediastinal
lesions were masses with a diameter > 50 mm, a hypoe-
choic appearance and an inhomogeneous echotexture.
The time for the entire contrast enhanced procedure
(from setting the machine, and preparing and injecting
the contrast until the end of the cine-segment) was five
min. No adverse effects were noticed in any of the dogs
during or after injection of the contrast medium. Quali-
tative evaluation was possible in all subjects imaged.
Concerning pulmonary diseases, the majority of malig-
nant lesions (16/17) showed an inhomogeneous enhance-
ment at PI with anechoic areas inside the lesions (Fig. 2).
Four benign lesions (4/6) showed a homogenous enhance-
ment with linear hyperechoic pulmonary structures
branching out from the periphery (Fig. 3a and b). One
benign pulmonary lesion showed a rim enhancement of
the lesion with an anechoic centre (Fig. 4). Table 4
summarizes all CEUS patterns of pulmonary lesions.
Most of the malignant mediastinal lesions (10/15)
showed an inhomogeneous distribution of the contrast
medium at PI characterized by extended areas lacking con-
trast medium (Fig. 5a), whereas the other malignant lesions
(5/15) had a homogenous perfusion pattern (Fig. 5b). In-
homogeneous enhancement and peripheral enhancement
of the lesion with an anechoic center was found in the
other two benign lesions, respectively (Table 5).
Quantitative analysis was performed in 19/23 pulmonary
lesions (Table 6). Excessive respiratory motion precluded
quantitative analysis in the remaining four pulmonary le-
sions, all of which were malignant. There was a statistically
significant difference between the AT of the malignant and
benign pulmonary lesions (P < 0.001) (Fig. 6).
Table 1 Final diagnosis in the malignant and benign patient
groups
Localization Final Diagnosis Number
of lesions
Number
of dogs
Number
of cats
LUNG MALIGNANT
Carcinoma 14 10 4
Sarcoma 1 1 0
Histiocytic sarcoma 1 1 0
Lymphoma 1 0 1
BENIGN
Pneumonia 5 5 0
Abscess 1 1 0
MEDIASTINUM MALIGNANT
Lymphoma 8 4 4
Thymoma 3 2 1
Myxosarcoma 1 1 0
Mesothelioma 1 1 0
Carcinomatous
lymphadenopathy
1 1 0
Melanoma 1 1 0
BENIGN
Lipoma 1 0 1
Abscess 1 0 1
Total 40 28 12
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Discussion
This is the first study evaluating the use of CEUS in the
characterization of non-cardiac thoracic disorders in small
animals. Contrast-enhanced ultrasound appeared to be
feasible when examining pulmonary and mediastinal le-
sions in dogs and cats, giving useful information for the
clinician. No adverse reactions have been reported and
even patients with respiratory distress, once stabilized,
could be submitted to CEUS examination safely. Different
patterns of enhancement have been observed for various
disease processes, and the timing of contrast uptake varied
between benign and malignant pulmonary lesions. More-
over, the contrast distribution within the lesion could help
in identifying areas of poor or null perfusion, likely refer-
able to regions of ischemia or necrosis; therefore, guiding
sample collections for cytological or histological examin-
ation and possibly increasing diagnostic accuracy.
While in veterinary medicine little has been published
concerning CEUS for the evaluation of thoracic lesion
[19, 20], several studies are available in the human
literature [11–15]. The CEUS patterns of our inflamma-
tory pulmonary lesions were similar to those previously
reported in humans [10, 11, 13, 14]. In particular, in
pneumonia, the CEUS pattern was characterized by a
rapid distribution of the contrast medium into the
branches of pulmonary arteries giving a typical treelike
appearance. Subsequently, a homogeneous and intense tis-
sue enhancement during the parenchymal phase was seen.
Conversely, the majority of our neoplastic pulmonary
lesions showed an inhomogeneous distribution of the
contrast media with different sized avascular areas be-
cause of chaotic neoplastic neoangiogenesis and necrosis.
In human medicine, lung cancer is usually characterized
by sparse tissue enhancement suggesting a bronchial ar-
terial supply [10, 11]. In particular, tumor neoangiogenesis
in human lung cancer is reported to arise from bronchial
arteries while pulmonary arteries seem to have no or a
low capacity for neoangiogenesis [10]. However, some
lung cancer subentities, such as bronchioloalveolar carcin-
oma and adenocarcinoma, may instead present with a
Table 2 Baseline grey-scale ultrasonography of 23 pulmonary lesions
Pulmonary
lesions
Location Shape Margins Echogenicity Echotexture Size
MALIGNANT Carcinoma
(14)
LAL (3) LAR (1)
LDL (4)
LDR (4)
MULTIFOCAL (2)
Rounded (5)
Oval (9)
Well-defined (14) Hypoechoic (14) Inhomogeneous (14) < 50 mm (6)
> 50 mm (8)
Sarcoma (1) LDL Rounded Well-defined Hypoechoic Inhomogeneous > 50 mm
Histiocytic sarcoma (1) LDL Oval Well-defined Heterogeneously
anechoic
Inhomogeneous < 50 mm
Lymphoma (1) MULTIFOCAL Rounded Well-defined Hypoechoic Inhomogeneous < 50 mm
BENIGN Pneumonia (5) LAL (1)
LMR (1)
LDR (1)
MULTIFOCAL (2)
Triangular Well-defined (3)
Ill-defined (2)
Hypoechoic (5) Homogeneous (4)
Inhomogeneous (1)
> 50 mm (1)
< 50 mm (4)
Abscess (1) LDR Oval Capsulated Heterogeneously
anechoic
NA < 50 mm
LAL apical left lobe, LDL diaphragmatic left lobe, LAR apical right lobe, LMR medium right lobe, LDR diaphragmatic right lobe
Table 3 Baseline grey-scale ultrasonography of 17 mediastinal lesions
Mediastinal
lesions
Location Shape Margins Echogenicity Echotexture Size
MALIGNANT Lymphoma (8) Cr Med (8) Rounded (3)
Oval (5)
Well-defined (8) Hypoechoic (8) Inhomogeneous (7)
Homogeneous (1)
< 50 mm (3)
> 50 mm (5)
Thymoma (3) Cr Med (3) Oval (3) Well-defined (3) Hypoechoic (3) Inhomogeneous (3) > 50 mm
Myxosarcoma (1) Cr Med Oval Well-defined Hypoechoic Inhomogeneous > 50 mm
Mesothelioma (1) Cr Med Oval Well-defined Hypoechoic Inhomogeneous < 50 mm
Carcinomatous lymphadenopathy (1) Cr Med Oval Well-defined Hypoechoic Inhomogeneous < 50 mm
Melanoma (1) Cr Med Oval Well-defined Hypoechoic Inhomogeneous > 50 mm
BENIGN Abscess (1) Cau Med Oval Well-defined Heterogeneously
anechoic
NA < 50 mm
Lipoma (1) Cau Med Oval Well-defined Hypoechoic Homogeneous < 50 mm
Cr Med Cranial Mediastinum, Cau Med Caudal Mediastinum
Linta et al. BMC Veterinary Research  (2017) 13:141 Page 5 of 10
pneumonia-like contrast-enhanced sonographic patterns
because of a pulmonary arterial supply [10–12, 14, 15].
We did not find different CEUS behavior in our neo-
plastic pulmonary group, and all lung cancer cases
showed an inhomogeneous distribution of the con-
trast medium. The different CEUS behavior of adeno-
carcinoma between dogs and humans may be
explained by the proliferation of bronchial arteries in
canine primary and metastatic pulmonary tumors
while the pulmonary arteries are displaced or dis-
torted by tumor mass or occluded by thrombi [23].
Moreover, the low number of cases enrolled in the
present study might also contribute to the discrepan-
cies observed between dogs and human patients.
Concerning mediastinal lymphoma, we found a differ-
ent CEUS pattern related to the dimension of the le-
sions. Lesions with a diameter less than 50 mm showed
a homogeneous enhancement, while those greater than
50 mm were characterized by an inhomogeneous pattern
with avascular areas. This CEUS behavior is similar to
that reported in human medicine where lymphomas
have a more variable CEUS appearance [24, 25]. Our
other mediastinal tumors (thymoma, myxosarcoma,
melanoma, carcinomatous lymphadenopathy, and meso-
thelioma) showed an inhomogeneous enhancement and
all of these tumors had a diameter greater than 50 mm.
In our cases, qualitative assessment of contrast medium
distribution was useful for differentiating benign from
Fig. 2 Transverse scan of a cocker spaniel dog with pulmonary carcinoma in the contrast enhancement image (a) and the grey scale image (b),
respectively. At peak intensity the mass showed an irregular distribution of the vessels associated with an inhomogeneous enhancement
Fig. 3 Longitudinal scan of right caudal pulmonary lobe of a crossbreed dog with pneumonia at wash in (a) and at peak intensity (b). Each
image illustrates contrast enhancement on the left and the grey scale image on the right. (a) There is an intense enhancement of the pulmonary
arteries (asterisks) with a typical tree-like ramification. (b) Intense and homogeneous enhancement of the entire lobe at peak intensity
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malignant lung lesions. All pneumonia cases showed
a homogeneous enhancement with the pulmonary ar-
teries observed as linear hyperechoic structures with
greater enhancement compared to the parenchyma,
whereas the majority of lung neoplasia (16/17 cases)
had an inhomogeneous pattern with avascular areas.
These findings suggest that CEUS can help in differ-
entiating between lesions of different nature. If CEUS
could increase the diagnostic accuracy of conventional
ultrasound is unable to be assessed based on the
present study. The shape of the lesions, the distribu-
tion and ramification of bronchi and vessels, and the
echo-texture observed with conventional ultrasound
were already highly suggestive of an inflammatory or
neoplastic process, as already described in veterinary
literature [3]. In the present study, we did not include
patients with pulmonary infiltrative tumors that might
mimic pneumonia (i.e. round cell neoplasia). It would
be an intriguing aspect of CEUS, if this technique
could help in differentiating these subtle processes
that cannot otherwise be easily discriminated using
conventional ultrasound. A unique type of lesion is
represented by the abscess. This process organizes as
a mass that could be misdiagnosed with a solid
tumor when using conventional ultrasound. In this
specific case, CEUS appears particularly helpful,
since it shows a characteristic pattern of contrast
distribution with intense peripheral rim enhancement
and anechoic center that is not usually present in
solid tumors, unless extensive intralesional necrosis
occurs sparing exclusively the peripheral rim (this
condition is unlikely to occur with this tidy fashion).
In our case report all abscesses had a unique CEUS
pattern, similar to what was observed in human
lungs and livers [18, 26].
In human medicine, the differentiation between be-
nign and malignant pulmonary lesions is based on the
different hemodynamic behaviors of the contrast
Fig. 4 Transverse scan of a right caudal pulmonary lobe of an English setter dog with pulmonary abscess in the contrast enhancement image (a)
and the grey scale image (b), respectively. At peak intensity the lesion was characterized by a peripheral enhancement with avascular center
Table 4 CEUS findings of 23 pulmonary lesions
Pulmonary lesions Wash-in Peak intensity Wash-out
MALIGNANT Carcinoma (14) Homogeneous (1)
Inhomogeneous (13)
Homogeneous (1)
Inhomogeneous (13)
Inhomogeneous (14)
Sarcoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
Histiocytic sarcoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
Lymphoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
BENIGN Abscess (1) Homogeneous enhancement of wall
and avascular center
Homogeneous enhancement
of wall and avascular center
Inhomogeneous enhancement
of wall and avascular center
Pneumonia (5) Homogeneous with normal vessels
ramification (4)
Homogeneous (4) Inhomogeneous with normal
vessels ramification (5)
Inhomogeneous with normal
vessels ramification (1)
Inhomogeneous (1)
Linta et al. BMC Veterinary Research  (2017) 13:141 Page 7 of 10
medium by measuring the time to enhancement. Be-
nign lesions have a shorter time to enhancement (due
to pulmonary artery supply: 2–6 s) compared to ma-
lignant lesions (due to bronchial artery supply: 7–
20 s) [10, 11]. This result has been recently reported
in a single abstract describing the CEUS ultrasonog-
raphy in fifteen small animals affected by peripheral
pulmonary and mediastinal mass lesions [20]. Particu-
larly, the authors described a significant difference in
time to enhancement between carcinomas and sarco-
mas and between carcinomas and inflammatory le-
sions [20]. Quantitative analysis of our pulmonary
lesions showed a statistical difference in the arrival
time of the contrast medium between inflammatory
and neoplastic groups. This finding is in agreement
with that reported in human medicine and can be ex-
plained by the difference in vascularization between
the two groups of lesions. Vascularization in benign
inflammatory lesions is mainly related to pulmonary
arteries, whereas in neoplastic lesions it is a conse-
quence of bronchial origin neovascularization.
All the FNA or TB performed after administration of
the contrast medium were successfully diagnostic. In hu-
man literature, several studies demonstrated the utility
of CEUS as a guide for transthoracic biopsy to avoid
necrotic areas inside large masses. Its diagnostic accur-
acy was reported around 93.6% [16, 27]. Although real
time ultrasonography can disclose the presence of necro-
sis inside the lesion and sonographic guidance is consid-
ered particularly useful in the diagnosis of pulmonary
masses with necrotic centers, inadequate specimens have
been reported in 9–26% of cases when the necrotic com-
ponent is large [28]. In our cases, avascular areas con-
sistent with necrosis were more frequently found in
masses with a diameter greater than 50 mm. This value
is also reported in human medicine causing false nega-
tive results during sample collections for cytological
examination [16, 27].
Fig. 5 Transverse scan of a thymoma in a crossbreed dog (a) and of a mediastinal lymphoma in a domestic short hair cat (b). Each image
illustrates contrast enhancement on the left and the grey scale image on the right. (a) There is an inhomogeneous enhancement of the mass at
peak intensity with avascular areas. (b) The mass showed an intense and homogenous enhancement at peak intensity
Table 5 CEUS findings of 17 mediastinal lesions
Mediastinal
lesions
Wash-in Peak intensity Wash-out
MALIGNANT Lymphoma (8) Homogeneous (4) Homogeneous (4) Inhomogeneous (8)
Inhomogeneous (4) Inhomogeneous (4)
Thymoma (3) Homogeneous (1) Homogeneous (1) Inhomogeneous (3)
Inhomogeneous (2) Inhomogeneous (2)
Mixsosarcoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
Mesothelioma (1) Inhomogeneous Inhomogeneous Inhomogeneous
Carcinomatous
lymphadenopathy (1)
Inhomogeneous Inhomogeneous Inhomogeneous
Melanoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
BENIGN Abscess (1) Homogeneous enhancement of
wall and avascular center
Homogeneous enhancement of
wall and avascular center
Inhomogeneous enhancement of
wall and avascular center
Lipoma (1) Inhomogeneous Inhomogeneous Inhomogeneous
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This study has some limitations that need to be
emphasized. First, the relatively low number of cases
and type of diseases observed. Second, out of the 19
pulmonary lesions quantified, 13 were malignant and
6 were benign; this unbalance could have influenced
the statistical analysis. Third, most of our final diag-
noses were obtained by FNA, which limited the possi-
bility of further classifying the lesions by histological
type, especially for lung tumors. In human medicine,
a different CEUS behavior of bronchioloalveolar car-
cinoma and adenocarcinoma in comparison to other
lung tumors have been reported [10, 11, 14, 15].
Finally, although CEUS appears useful in characteriz-
ing intra-thoracic lesions of different natures, conven-
tional ultrasound was already able to provide most of
the information needed to hypothesize the benign or
malignant behavior of the lesions. A larger number of
cases and the characterization of different pathological
processes are needed to understand if CEUS could
outperform conventional ultrasound in discriminating
between thoracic lesions.
Conclusions
In conclusion, we have demonstrated the feasibility of
CEUS in the evaluation of canine and feline lung and
mediastinal disorders. The injection of a microbubble
contrast medium allows for precise definition of
lesion edges, the presence of necrotic areas, and the
distribution of pulmonary vessels. Most of the pul-
monary and mediastinal malignant lesions were char-
acterized by an inhomogeneous distribution of the
contrast medium, whereas homogenous tissue en-
hancement with regular branching distribution of
pulmonary arterial vessels was seen with pneumonia.
A distinctive contrast perfusion pattern for the differ-
ent types of malignant lesions was not obtained and
an increased number of cases will be necessary for
characterization.
Based on our preliminary results, the use of CEUS can
be recommended as a direct guide for sampling proce-
dures to improve the diagnostic success of cytological
and histological sampling.
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Table 6 Quantitative computerized analysis of the contrast medium blood pool phase of 19 pulmonary lesions
Pulmonary lesions MALIGNANT median (range) BENIGN median (range) P-value
Number of lesions 13 6
AT 7.27 (4.46–13.52) 4.52 (2.87–6.06) < 0.001*
TTPinj 13.78 (10.24–24.50) 9.83 (4.70–13.35) 0.059
TTPinr 5.91 (3.79–14.87) 4.55 (1.83–9.56) 0.236
PI 2.37 (0.68–11.87) 3.17 (1.63–8.56) 0.273
Wi 0.25 (0.10–1.99) 0.45 (0.20–1.96) 0.242
AT Arrival Time, TTPinj time to peak from injection, TTPinr time to peak from initial rise, PI peak intensity, Wi wash-in rate
*Statistically significant
Fig. 6 Signal intensity in arbitrary units (a.u.) as a function of time in
seconds of two representative cases included in the study. Grey line
refers to a crossbreed dog with pneumonia while the black line
refers to a crossbreed dog with pulmonary carcinoma. Note the
delayed contrast agent arrival (expressed as arrival time [AT]) shown
by the carcinoma in comparison to the pneumonia. PI, peak
intensity (expressed in arbitrary units [a.u.]); Wi, wash-in slope
(expressed in a.u./sec)
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